Status:
WITHDRAWN
Use of Hyperbaric Oxygen Therapy for the Treatment of Crush Injuries
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
Winthrop University Hospital
Conditions:
Crush Injury
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether using hyperbaric oxygen (HBO) improves wound healing for patients who have a crush injury. The comparison of the prospective intervention group to the...
Eligibility Criteria
Inclusion
- Presenting to NYU Winthrop Hospital with a crush injury of the extremity, including appendages, up to 14 days post injury.
- No contraindication to hyperbaric oxygen therapy.
- Able and willing to sign informed consent.
Exclusion
- Critically-ill patient requiring intubation or pressor support.
- Crush injury isolated to the distal phalanx (Tuft fracture).
- Absolute contraindication to hyperbaric oxygen therapy (untreated pneumothorax). Relative contraindications (uncontrolled congestive heart failure, uncontrolled seizure disorder, pulmonary disease, claustrophobia) will be assessed by the treating physician.
- Unable or unwilling to sign informed consent.
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04049721
Start Date
September 1 2021
End Date
September 1 2023
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016